Alpine immune sciences, inc. (ALPN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Collaboration revenue

2,831

1,740

856

567

390

705

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

0

0

-

-

-

-

Operating expenses:
Research and development

30,375

35,847

38,979

39,976

35,528

28,970

23,749

15,970

12,560

10,626

12,572

10,641

14,757

18,466

17,103

20,563

18,604

16,054

14,583

12,468

11,366

12,200

0

0

0

General and administrative

8,900

9,467

9,879

9,269

8,599

8,362

7,055

7,130

7,314

6,079

7,040

5,407

5,512

7,006

7,175

8,698

7,913

6,844

5,171

3,839

3,046

2,287

0

0

0

Loss on sale of intangible asset

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

39,275

45,314

48,858

49,245

45,330

38,535

32,007

24,303

19,874

16,705

12,906

0

0

-

0

-

-

-

-

-

-

-

-

-

-

Restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

0

0

-

-

-

-

Loss from operations

-36,444

-43,574

-48,002

-48,678

-44,940

-37,830

-31,174

-23,342

-18,565

-14,974

-18,009

-13,836

-18,795

-24,735

-23,541

-29,261

-26,517

-22,898

-19,754

-16,307

-14,412

-14,487

0

0

0

Other income (expense):
Business Combination, Bargain Purchase, Gain Recognized, Amount

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

439

-

292

175

80

0

0

0

-

-

-

-

Interest and other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Interest expense

388

338

273

289

311

319

319

312

230

152

76

0

0

0

-

-

0

0

0

392

633

845

0

0

0

Interest income

0

-

1,367

1,395

0

-

1,252

1,139

842

-

268

0

0

-

0

-

-

-

-

-

-

-

-

-

-

Loss before taxes

-

-

-46,908

-47,572

-

-36,853

-30,179

-15,914

-11,352

-7,983

-3,835

0

0

-

0

-

-

-

-

-

-

-

-

-

-

Income Tax Expense (Benefit)

-

-

-61

-61

-

-366

-509

-505

-252

-200

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gain on extinguishment of convertible debt as a capital transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Net loss

-35,004

-41,852

-46,847

-47,511

-43,562

-36,487

-29,670

-15,409

-11,100

-7,783

-11,178

-13,674

-18,555

-24,404

-23,254

-28,969

-26,342

-22,818

-20,119

-16,663

-15,000

-15,036

0

0

0

Comprehensive income (loss):
Unrealized (loss) gain on investments

-1

29

49

74

107

46

-13

-55

-105

-59

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on foreign currency translation

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Unrealized gains (losses) on marketable securities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

Comprehensive loss

-35,110

-41,829

-46,815

-47,447

-43,469

-36,441

-29,683

-15,464

-11,205

-7,842

11,962

9,478

4,617

-1,232

0

0

0

-

-

-

-

-

-

-

-

Weighted-average shares used to compute basic net income (loss) per share attributable to common stockholders (in shares)

-

-

-

-

-

-

-

-

-

-

10,577

-

-

-

608

-

-

-

-

-

-

-

-

-

-

Basic net income (loss) per share attributable to common stockholders (in dollars per share)

-

-

-

-

-

-

-

-

-

-

0.20

-

-

-

-0.61

-

-

-

-

-

-

-

-

-

-

Weighted-average shares used to compute diluted net income (loss) per share attributable to common stockholders (in shares)

-

-

-

-

-

-

-

-

-

-

11,586

-

-

-

608

-

-

-

-

-

-

-

-

-

-

Diluted net income (loss) per share attributable to common stockholders (in dollars per share)

-

-

-

-

-

-

-

-

-

-

0.18

-

-

-

-0.61

-

-

-

-

-

-

-

-

-

-

Weighted-average shares used to compute basic and diluted net loss per share (in shares)

18,587

18,600

18,586

18,576

17,671

13,852

13,851

13,848

13,844

-

-

666

615

15,540

-

15,462

15,462

15,452

15,451

4,159

2,209

2,891

0

0

0

Basic and diluted net loss per share (in dollars per share)

-0.30

-0.32

-0.62

-0.64

-0.70

-0.80

-0.88

-0.57

-0.38

-

-

-5.40

-3.23

-0.50

-

-0.55

-0.51

-0.42

-0.39

-1.41

-1.95

40.13

-7.68

-25.70

-27.02

Total stock-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-